SCHEMBL20161464

SCHEMBL20161464

NC(Cc1ccccc1F)c1cccnn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TSHR P16473 2/20 0.37
MAPK1 P28482 1/20 0.37
IDO1 P14902 2/20 0.36
DPP4 P27487 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 3/20 0.35
KCNH2 Q12809 2/20 0.35
DPP7 Q9UHL4 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
DPP8 Q6V1X1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3712032 0.77 CYP1A2 (0.46) TAAR1ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL20161327 0.74 NPC1 (0.38) TAAR1IDO1DPP4CYP3A4CYP2D6
SCHEMBL3282116 0.72 DPP4 (0.66) TAAR1IDO1DPP4CYP3A4CYP2D6
SCHEMBL27490477 0.72 CYP1A2 (0.40) CYP1A2GOT1
SCHEMBL3281088 0.72 KCNA5 (0.47) DPP4CYP3A4CYP2D6SLC6A2SLC6A4
SCHEMBL3281177 0.71 DPP4 (0.47) TAAR1IDO1DPP4CYP3A4CYP2D6
SCHEMBL12706272 0.71 TAAR1 (0.47) TAAR1ALDH1A1TSHRMAPK1IDO1
SCHEMBL12495185 0.71 CYP1A2 (0.42) CYP1A2GOT1
SCHEMBL8267903 0.70 TAAR1 (0.50) TAAR1ALDH1A1IDO1DPP4CYP3A4
SCHEMBL3674139 0.69 TAAR1 (0.54) TAAR1ALDH1A1IDO1DPP4CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12435080-B2 sGC stimulators TISENTO THERAPEUTICS INC. (US) 2025-10-07 US disclosed
US-20220017515-A1 sGC STIMULATORS TISENTO THERAPEUTICS INC. 2022-01-20 US disclosed
US-20220017515-A1 sGC STIMULATORS TISENTO THERAPEUTICS INC. 2022-01-20 US disclosed
US-11180493-B2 SGC stimulators CYCLERION THERAPEUTICS, INC. (US) 2021-11-23 US disclosed
US-11180493-B2 SGC stimulators CYCLERION THERAPEUTICS, INC. (US) 2021-11-23 US disclosed
US-20200071318-A1 SGC STIMULATORS TISENTO THERAPEUTICS INC. 2020-03-05 US disclosed
US-20200071318-A1 SGC STIMULATORS TISENTO THERAPEUTICS INC. 2020-03-05 US disclosed
WO-2018089330-A2 SGC STIMULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200071318-A1 SGC STIMULATORS GUCY1A2, GMPS, PDE2A TAAR1 2501/4885ALDH1A1 2298/4885TSHR 1534/4885
US-20220017515-A1 sGC STIMULATORS GUCY1A2, PRKG1, PDE2A TAAR1 2565/4885ALDH1A1 2355/4885TSHR 1525/4885
US-12435080-B2 sGC stimulators GUCY1A2, PRKG1, PDE2A TAAR1 2565/4885ALDH1A1 2355/4885TSHR 1525/4885
US-11180493-B2 SGC stimulators GUCY1A2, GMPS, PDE2A TAAR1 2501/4885ALDH1A1 2298/4885TSHR 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.